• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.59% Nasdaq Down 0.34%

    Array BioPharma, Inc. (ARRY)

    -NasdaqGM
    7.24 Down 0.23(3.02%) 2:51PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.46
    Open:7.43
    Bid:7.28 x 1200
    Ask:7.29 x 100
    1y Target Est:9.00
    Beta:2.98
    Next Earnings Date: 3-Feb-15ARRY Earnings announcement
    Day's Range:7.13 - 7.55
    52wk Range:2.98 - 8.01
    Volume:1,732,822
    Avg Vol (3m):3,161,900
    Market Cap:954.75M
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARRY

    Comparison

    Symbol% ChgMkt Cap
    ARRYDown 3.02%954.75M
    ARQLDown 0.43%71.87M
    BMYDown 0.44%100.97B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):29.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.67
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-1.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback